Avid Bioservices, Inc. (CDMO) — Financial statements
Income statement, balance sheet, and cash flow for Avid Bioservices, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 140↓6.3% | 149↑24.8% | 120↑24.8% | 96↑60.6% | 60 | |
| Cost of Revenue | 133↑12.6% | 118↑42.0% | 83↑24.6% | 67↑19.3% | 56 | |
| Gross Profit | 7↓76.8% | 31↓14.1% | 37↑25.0% | 29↑645.3% | 4 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 25↓7.3% | 27↑31.8% | 21↑23.0% | 17↑17.1% | 14 | |
| Selling & Marketing Expenses | 0.80↑14.3% | 0.70↑16.7% | 0.60↑100.0% | 0.30↑50.0% | 0.20 | |
| SG&A Expenses | 26↓6.8% | 28↑31.3% | 21↑24.4% | 17↑17.5% | 15 | |
| Other Expenses | 0.00 | 0.00↑100.0% | -0.08↓160.9% | 0.13 | 0.00 | |
| Operating Expenses | 26↓6.8% | 28↑31.3% | 21↑24.4% | 17↑17.5% | 15 | |
| Total Costs & Expenses | 159↑8.9% | 146↑39.8% | 104↑24.6% | 84↑19.0% | 70 | |
| Operating Results | ||||||
| Operating Income | -19↓616.5% | -3↓124.0% | 11↑21.7% | 9↑184.3% | -11 | |
| Depreciation & Amortization | 11↑54.1% | 7↑60.9% | 4↑29.7% | 3↑11.7% | 3 | |
| EBITDA | -11↓205.2% | 11↓45.2% | 20↑26.8% | 16↑312.8% | -7 | |
| EBIT | -23↓710.4% | 4↓76.0% | 15↑26.0% | 12↑217.1% | -10 | |
| Interest & Other Income | ||||||
| Net Interest Income | -4↓43.9% | -3↓12.4% | -3↓130.2% | -1↓14450.0% | -0.01 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 4↑43.9% | 3↑12.4% | 3↑130.2% | 1↑14450.0% | 0.01 | |
| Non-Operating Income | 4↑4012.0% | -0.10 | 0.00 | 0.00↑100.0% | -0.13 | |
| Other Income / Expenses | -8↓310.2% | -2↑27.2% | -3↓167.8% | -1↓966.4% | 0.12 | |
| Income Before Tax | -27↓1444.3% | 2↓84.2% | 13↑12.9% | 11↑207.1% | -10 | |
| Income Tax Expense | 114↑7788.1% | 1↑101.3% | -115 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -141↓54444.8% | 0.26↓99.8% | 128↑1038.7% | 11↑207.1% | -10 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -141↓25234.5% | 0.56↓99.6% | 128↑1038.7% | 11↑254.5% | -7 | |
| Bottom-Line Net Income | -141↓54444.8% | 0.26↓99.8% | 130↑3806.8% | 3↑121.9% | -15 | |
| EPS (Basic) | -2.23↓24877.8% | 0.01↓99.6% | 2.08↑3549.1% | 0.06↑143.8% | -0.13 | |
| EPS (Diluted) | -2.23↓25440.9% | 0.01↓99.5% | 1.81↑3143.7% | 0.06↑142.9% | -0.13 | |
| Weighted Average Shares | 63↑1.5% | 62↑1.3% | 61↑5.6% | 58↑3.4% | 56 | |
| Weighted Average Diluted Shares | 63↓0.9% | 64↓9.5% | 70↑18.6% | 59↑5.5% | 56 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.